LFWD Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 2.06%, SMA50 -10.42%, SMA200 -25.97%). The stock’s 14-day RSI is 49.39 (neutral), while the ATR of 0.71 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -81.72% below its high and over 56.28% above its low. Average 10-day trading volume of 16.83 thousand shares is below the 3-month average of 27.72 thousand, indicating normal recent market interest.

Lifeward Ltd. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$4.89. This means the shares are trading below this model’s fair value.

Lifeward Ltd. (NASDAQ:LFWD) closed at $7.56 USD, gaining $0.17 (2.30%) from the previous close of $7.39. The stock is currently mid-range between its 52-week high and low $4.14 and $23.04. With a market capitalization of about $11.53 million, Lifeward Ltd. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.14). Key stats such as the average daily volume over the past year has been around 27.57 thousand shares, volume is running light vs its 52-week average. Headquartered in Yokneam Illit, None, Lifeward Ltd. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO William Mark Grant, the company employs approximately 80 people and listed since September 12, 2014. Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons.

Lifeward Ltd. generated EPS of -$35.73 over the past year. Five-year average earnings growth is 29.33%. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $4.50 to $4.50. The high target offers -40.48% upside. The low target suggests -40.48% downside. The mean target is $4.50. This offers -40.48% upside. Lifeward Ltd. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 14, 2025, missed forecasts by 207.69%. The prior quarter beat by 132.0%. Over the last six quarters, Apple has recorded several small beats. These include -104.08% in August 15, 2024.

Lifeward Ltd. has 15.60 million shares outstanding. The public float is 15.42 million shares, elevated short interest at 9.67% of float. This equals 1.48 million shares. The short ratio is 2.19 days. Institutional investors hold 2.95% of the float. Insiders own 2.07%. Lind Global Fund II LP holds 858.00 thousand shares, Jasinski Lawrence J has 98.73 thousand shares and Swinford Michael has 65.04 thousand shares.

Lifeward Ltd. trades at a P/E ratio of -0.34, slightly below the S&P 500 average, with a price-to-sales ratio of 0.47 and a price-to-book ratio of 0.79 suggesting the stock is closer to book value. The P/FCF stands at -0.67, also above market averages.

Lifeward Ltd. (NASDAQ:LFWD) shares are up 25.06% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Lifeward Ltd. trading at a premium to the broader market with a P/E of -0.34. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $8.86, suggesting 17.2% upside. Our AI forecast model points to short-term strength (0.13% over two weeks), a medium-term fall (-21.69% over three months), and a longer-term loss (-53.7% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Lifeward Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.13%, with price expected at $7.57 by March 31, 2026, within a range of $6.90 to $8.17 3-Month Outlook: Projected fall of -21.69%, reaching $5.92 by June 15, 2026, with a range of $5.16 to $6.64. 1-Year Outlook: Projected loss of -53.7%, with price at $3.50 by March 17, 2027, within a range of $0.00 to $3.17.